← Leaderboards
Karen A Graham
University Of North Carolina Chapel Hill
$51,288
Attributed
$51,288
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $13.4K · FY2005–08$20K$15K$10K$5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$51,288 · 7
By mechanism
M01$51,288 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Douglas A Drossman$8,090,089
- Linmarie Sikich$18,880,212
- Jeffrey A Lieberman$17,412,506
- John B Buse$71,388,050
- Linda M Nicholas$1,559,955
Others in their field
Top investigators on “Weight Gain”
- David M Nathan · Massachusetts Institute Of Technology$134,440,411
- John M Lachin · George Washington University$118,921,924
- Leonardo Trasande · New York University School Of Medicine$53,629,363
- William J. Blot · Vanderbilt University$35,230,632
- Assiamira Ferrara · Kaiser Foundation Research Institute$32,768,414
- Mark Andrew Espeland · Wake Forest University Health Sciences$30,972,309
Research focus
Weight GainResearch PersonnelInstitutionUnited States National Institutes Of HealthOlanzapineFundingResourcesGrantSourceComputer Retrieval Of Information On Scientific Projects DatabaseBlood GlucoseRisperidoneWeight Gain PreventionAmantadineAripiprazoleBlood PressureInvestigationLipidsPharmaceutical PreparationsPreventPurposeQuetiapineAdultDrug Adverse Effect
Grant awards (9)
AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ$2,066
M01 · FY2008 · RR · contact PI
INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE$612
M01 · FY2008 · RR · contact PI
AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ$7,878
M01 · FY2007 · RR · contact PI
INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE$4,877
M01 · FY2007 · RR · contact PI
WEIGHT GAIN WITH OLANZAPINE, QUETIAPINE AND RISPERIDONE IN SUBJECTS WITH PSYCHOS$7,186
M01 · FY2006 · RR · contact PI
INVESTIGATION OF BMI, ETC CHANGES FOLLOWING A SWITCH FROM OLANZAPINE$3,717
M01 · FY2006 · RR · contact PI
AMANTADINE FOR PREVENTION OF WEIGHT GAIN IN FIRST EPIDSODE ADULT PSYCHOTIC SUBJ$2,478
M01 · FY2006 · RR · contact PI
WEIGHT GAIN WITH OLANZAPINE, QUETIAPINE AND RISPERIDONE IN SUBJECTS WITH PSYCHOS$9,738
M01 · FY2005 · RR
Weight Gain with Olanzapine, Quetiapine and Risperidone in Subjects with Psychos$12,736
M01 · FY2004 · RR